Cardiex Ltd (CDX)

Sydney
0.340
-0.040(-10.53%)
  • Volume:
    222,265
  • Bid/Ask:
    0.340/0.380
  • Day's Range:
    0.340 - 0.370

CDX Overview

Prev. Close
0.38
Day's Range
0.34-0.37
Revenue
4.92M
Open
0.37
52 wk Range
0.25-0.77
EPS
-0.09
Volume
222,265
Market Cap
37.4M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
129,014
P/E Ratio
-
Beta
1.91
1-Year Change
-45.59%
Shares Outstanding
110,003,700
Next Earnings Date
19 Aug 2022
What is your sentiment on Cardiex?
or
Market is currently closed. Voting is open during market hours.

Cardiex Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Cardiex Ltd Company Profile

Cardiex Ltd Company Profile

Cardiex Limited is an Australia-based global health technology company. The Company is engaged in designing, manufacturing and marketing medical devices for use in cardiovascular health management. It is focused on hypertension, cardiovascular disease, and other vascular health disorders. It operates through its subsidiaries, including ATCOR and CONNEQT. The Company's ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the ATCOR.X brand, the Company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. Its digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients' health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness parameters.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell